Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BLNK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZFHX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUGT1P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYLD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100129518 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C7orf49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM183CP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNFX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-DQB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RETNLB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUC5AC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929717 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF213 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on